SPOTLIGHT: Iraqi-bribe probe touches Glaxo, AZ

The feds are shining a spotlight on drug makers suspected of bribing Saddam Hussein's regime. Allegedly, the pharma companies wanted a piece of the oil-for-food action, which allowed petrol money to pay for humanitarian goods--such as drugs. GlaxoSmithKline and AstraZeneca are among those asked for documents related to those sales; the companies deny wrongdoing. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.